ANNAPOLIS, Md., Nov. 7, 2013 /PRNewswire/ --
Recent Highlights
-- On track to commence SparVax(R) Phase 2 clinical trial
-- Presented new SparVax(R) anthrax vaccine data at the 2013 Bacillus-ACT International Conference and the 53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Help employers find you! Check out all the jobs and post your resume.
